VistA-WorldVistAEHR/r/ONCOLOGY-ONC/ONCOANCF.m

ONCOANCF ;Hines OIFO/GWB -  ACOS Reporting Paramenters ;06/14/00
 ;;2.11;ONCOLOGY;**1,15,25,26**;Mar 07, 1995
DATA ;
 ;;RECORD TYPE^1^1
 ;;Patient ID number^2^9
 ;;Registry type^10^10
 ;;Registry ID^11^18
 ;;Address at diagnosis-city^19^38
 ;;Address at diagnosis-state^39^40
 ;;County of residence at diagnosis^41^43
 ;;Address at diagnosis-ZIP^44^52
 ;;Blank^53^59
 ;;Marital status^60^60
 ;;Race^61^62^1
 ;;Race coding system - Current^63^63
 ;;Race coding system - Original^64^64
 ;;Spanish Surname/Origin (Ethnicity)^65^65^1
 ;;Sex^66^66^1
 ;;Age at diagnosis^67^69
 ;;Date of birth^70^77^1
 ;;Place of birth^78^80
 ;;Religon^81^82
 ;;Blank^83^106
 ;;Tumor record number^107^108
 ;;Sequence number^109^110^1
 ;;Date of initial diagnosis^111^118^1
 ;;Primary site^119^122^1
 ;;Laterality^123^123^1
 ;;Histology^124^128^1
 ;;Grade or differentiation^129^129^1
 ;;Site coding system - Current^130^130
 ;;Site coding system - Original^131^131
 ;;Morphology coding system - Current^132^132
 ;;Blank^133^133
 ;;Diagnostic confirmation^134^134^1
 ;;Type of reporting source^135^135
 ;;Accession year^136^137^1
 ;;Blank^138^141
 ;;Reporting (diagnosis) hospital^142^149
 ;;Accession number (hospital)^150^155^1
 ;;Blank^156^158
 ;;Date of admission^159^166
 ;;Date of discharge^167^174
 ;;Class of case^175^175^1
 ;;RX hospital-surgery type^176^177
 ;;RX hospital-radiation^178^178
 ;;RX hospital-chemotherapy^179^179
 ;;RX hospital-hormone/steroid^180^180
 ;;RX hospital-biological response modifier^181^181
 ;;RX hospital-other cancer-directed therapy^182^182
 ;;General Summary Stage^183^183^1
 ;;Local/Regional/Distant stage^184^184
 ;;EOD-Tumor size^185^187^1
 ;;EOD-Extension^188^189
 ;;EOD-Lymph nodes^190^190
 ;;Regional nodes positive^191^192^1
 ;;Regional nodes examined^193^194^1
 ;;Blank^195^213
 ;;T code of TNM (pathologic)^214^215^2:221,222
 ;;N code of TNM (pathologic)^216^217^2:223,224
 ;;M code of TNM (pathologic)^218^218^2:225,225
 ;;AJCC Stage Group (Path)^219^220^2:226,227
 ;;T code (Clinical)^221^222^2:214,215
 ;;N code (Clinical)^223^224^2:216,217
 ;;M code (Clinical)^225^225^2:218,218
 ;;AJCC Stage Group (Clinical)^226^227^2:219,220
 ;;TNM Edition Number^228^228
 ;;Distant Metastasis^229^231^1
 ;;Surgical Margins^232^232
 ;;Blank^233^236
 ;;Tumor Marker 1^237^237
 ;;Tumor Marker 2^238^238
 ;;Blank^239^250
 ;;Treatment coding system^251^251
 ;;RX date-surgery^252^259
 ;;RX date-radiation^260^267
 ;;RX date-chemotherapy^268^275
 ;;RX date-hormone/steroid therapy^276^283
 ;;RX date-biological response modifier^284^291
 ;;RX date-other cancer-directed therapy^292^299
 ;;RX date-started^300^307^1
 ;;RX summary-surgery type^308^309^1
 ;;Reason for no cancer-directed surgery^310^310
 ;;RX summary-radiation^311^311^1
 ;;Radiation to brain and central nervous system^312^312
 ;;RX summary-Radiation therapy sequence with surgery^313^313
 ;;RX summary-chemotherapy^314^314^1
 ;;RX summary-hormone/steroid (endocrine) therapy^315^315
 ;;RX summary-biological response modifier^316^316^1
 ;;RX summary-other cancer-directed therapy^317^317^1
 ;;Blank^318^337
 ;;#1  Subsequent RX-date (started)^338^345^
 ;;#1    Surgery^346^347^
 ;;#1    Radiation^348^348
 ;;#1    Chemotherapy^349^349
 ;;#1    Hormone/steroid therapy^350^350
 ;;#1    Biological response modifier^351^351
 ;;#1    Other cancer-directed therapy^352^352
 ;;#2  Subsequent RX-date (started)^353^360
 ;;#2    Surgery^361^362
 ;;#2    Radiation^363^363
 ;;#2    Chemotherapy^364^364
 ;;#2    Hormone/steroid therapy^365^365
 ;;#2    Biological response modifier^366^366
 ;;#2    Other cancer-directed therapy^367^367
 ;;#3  Subsequent RX-date (started)^368^375
 ;;#3    Surgery^376^377
 ;;#3    Radiation^378^378
 ;;#3    Chemotherapy^379^379
 ;;#3    Hormone/steroid therapy^380^380
 ;;#3    Biological response modifier^381^381
 ;;#3    Other cancer-directed therapy^382^382
 ;;#4  Subsequent RX-date (started)^383^390
 ;;#4    Surgery^391^392
 ;;#4    Radiation^393^393
 ;;#4    Chemotherapy^394^394
 ;;#4    Hormone/steroid therapy^395^395
 ;;#4    Biological response modifier^396^396
 ;;#4    Other cancer-directed therapy^397^397
 ;;Blank^398^417
 ;;Date of last contact^418^425^1
 ;;Vital status^426^426^1
 ;;Cancer status^427^427^1
 ;;Quality of survival^428^428
 ;;Blank^429^460
 ;;First recurrence-date^461^468^
 ;;First recurrence-type^469^469^
 ;;First recurrence-distant site(s)^470^472^
 ;;Cause of death^473^476
 ;;ICD revision number^477^477
 ;;Blank^478^481
 ;;Blank^482^502
 ;;Blank^503^522
 ;;ACOS coding system - Current^523^523
 ;;Blank^524^525
 ;;Vendor Name^526^535
 ;;AACCR Record Version^536^536
 ;;Blank^537^550
 ;;
 ;;